{{Rsnum
|rsid=12885300
|Gene=DIO2
|Chromosome=14
|position=80211923
|Orientation=plus
|GMAF=0.2287
|Gene_s=DIO2,RPL29P25
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 42.9 | 42.0 | 15.2
| HCB | 73.5 | 23.5 | 2.9
| JPT | 71.7 | 27.4 | 0.9
| YRI | 97.3 | 2.7 | 0.0
| ASW | 87.7 | 12.3 | 0.0
| CHB | 73.5 | 23.5 | 2.9
| CHD | 71.3 | 25.0 | 3.7
| GIH | 58.4 | 35.6 | 5.9
| LWK | 99.1 | 0.9 | 0.0
| MEX | 43.1 | 50.0 | 6.9
| MKK | 85.9 | 14.1 | 0.0
| TSI | 41.2 | 46.1 | 12.7
| HapMapRevision=28
}}{{PMID Auto
|PMID=19427350
|Title=Association of genetic polymorphisms in the type II deiodinase gene with bipolar disorder in a subset of Chinese population
}}

{{PMID Auto
|PMID=21400473
|Title=Osteoarthritis susceptibility genes influence the association between hip morphology and osteoarthritis
}}

{{PMID Auto
|PMID=21715540
|Title=The Type 2 Deiodinase ORFa-Gly3Asp Polymorphism (rs12885300) Influences the Set Point of the Hypothalamus-Pituitary-Thyroid Axis in Patients Treated for Differentiated Thyroid Carcinoma
}}

{{PMID|18334578}} Identification of DIO2 as a new susceptibility locus for symptomatic osteoarthritis.

{{PMID|18492748|OA=1
}} A common variation in deiodinase 1 gene DIO1 is associated with the relative levels of free thyroxine and triiodothyronine.

{{PMID|18815314|OA=1
}} Cellular and molecular basis of deiodinase-regulated thyroid hormone signaling.

{{PMID|22307573|OA=1
}} The -258A/G (SNP rs12885300) polymorphism of the human type 2 deiodinase gene is associated with a shift in the pattern of secretion of thyroid hormones following a TRH-induced acute rise in TSH.

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}